Invention Grant
- Patent Title: Chalcone-based chemotherapeutic compound for triple negative breast cancer
-
Application No.: US16440861Application Date: 2019-06-13
-
Publication No.: US11746104B2Publication Date: 2023-09-05
- Inventor: Ashraf Khalil , Ala-Eddin Al Moustafa , Dana H. Elkhalifa , Feras Alali
- Applicant: QATAR UNIVERSITY
- Applicant Address: QA Doha
- Assignee: QATAR UNIVERSITY
- Current Assignee: QATAR UNIVERSITY
- Current Assignee Address: QA Doha
- Agency: SQUIRE PATTON BOGGS (US) LLP
- Main IPC: A61K31/03
- IPC: A61K31/03 ; A61K31/035 ; C07C225/22 ; C07C317/32 ; C07D405/10 ; C07D413/10 ; C07D295/033 ; A61P35/00 ; C07C317/30 ; A61K45/06

Abstract:
Provided herein are compounds, compositions, and methods useful for the treatment of breast cancer, particularly triple negative breast cancers. In certain aspects, provided herein are compounds of formula (I):
or a pharmaceutically acceptable salt or solvate thereof. In certain aspects, provided herein are compositions comprising any of the compounds provided herein. In certain aspects, provided herein are methods for the treatment of cancer in a subject in need thereof comprising administering to the subject an effective amount of any of the compounds or compositions provided herein.
or a pharmaceutically acceptable salt or solvate thereof. In certain aspects, provided herein are compositions comprising any of the compounds provided herein. In certain aspects, provided herein are methods for the treatment of cancer in a subject in need thereof comprising administering to the subject an effective amount of any of the compounds or compositions provided herein.
Information query